Biostar Pharmaceuticals, Inc. (BSPM.OB) received local approval for three TCM products, which it expects to begin selling later this month. The company projects a total of $3.5 million in revenues from the three products in 2009, and $7.4 million in 2010. Biostar anticipates they will produce net income of $1 million this year and $2 million in 2010.
Biostar has built a rural cooperative medicine supply network to distribute these products alongside its existing drugs. The network currently consists of about 1,320 sales outlets in rural areas, which Biostar plans to expand into 10,000 sales outlets in two years.
The three new products are:
- Yizi Capsules – a TCM aimed at infertility in women and believed to aid in healthy fetal development during pregnancy. It is one of only a few nutritional supplement products marketed for infertility
Tags : infertility, suppliment, Yizi Capsules
